Silo Pharma Inc Stock Ownership - Who owns Silo Pharma?

Insider buying vs selling

Have Silo Pharma Inc insiders been buying or selling?
Daniel E. RyweckChief Financial Officer2023-05-261,000$2.13
Eric WeisblumCEO and President2023-05-18500$2.11
Eric WeisblumCEO and President2023-05-172,500$2.06
Eric WeisblumCEO and President2022-12-20130$2.72
Eric WeisblumCEO and President2022-12-19200$2.68
Eric WeisblumCEO and President2022-12-14263$3.17
Eric WeisblumCEO and President2022-12-13487$3.07

1 of 1

SILO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SILO insiders and whales buy or sell their stock.

SILO Shareholders

What type of owners hold Silo Pharma Inc stock?
Eric Weisblum4.99%157,724$348.57kInsider
Financial Advocates Investment Management1.41%44,507$98.36kInstitution
Geode Capital Management LLC0.78%24,542$54.24kInstitution
State Street Corp0.40%12,500$27.63kInstitution
Tower Research Capital LLC Trc0.17%5,491$12.14kInstitution
Daniel E. Ryweck0.16%5,000$11.05kInsider
Westside Investment Management Inc0.00%94$207.74Institution
Wells Fargo Company0.00%20$44.20Institution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 1

SILO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SILO2.76%5.15%Net BuyingNet Buying
AYTU1.80%98.20%Net Buying
WINT0.00%100.00%Net BuyingNet Buying

Silo Pharma Stock Ownership FAQ

Who owns Silo Pharma?

Silo Pharma (NASDAQ: SILO) is owned by 2.76% institutional shareholders, 5.15% Silo Pharma insiders, and 92.09% retail investors. Eric Weisblum is the largest individual Silo Pharma shareholder, owning 157,724.00 shares representing 4.99% of the company. Eric Weisblum's Silo Pharma shares are currently valued at $348.57k.

If you're new to stock investing, here's how to buy Silo Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.